Last reviewed · How we verify

China International Neuroscience Institution — Portfolio Competitive Intelligence Brief

China International Neuroscience Institution pipeline: 5 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Propofol half Propofol half marketed
2% Sevoflurane 2% Sevoflurane marketed
Preemptive Analgesia Of Dexmedetomidine Preemptive Analgesia Of Dexmedetomidine marketed Alpha-2 adrenergic agonist Alpha-2 adrenergic receptor Anesthesia and Pain Management
Preemptive Dexmedetomidine injection Preemptive Dexmedetomidine injection marketed Alpha-2 adrenergic receptor agonist Alpha-2 adrenergic receptor Anesthesia and Perioperative Medicine
hydroxyethl starch hydroxyethl starch marketed Synthetic colloid / Volume expander Critical Care / Anesthesia

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. American University of Beirut Medical Center · 2 shared drug classes
  2. Tang-Du Hospital · 2 shared drug classes
  3. Icahn School of Medicine at Mount Sinai · 2 shared drug classes
  4. Allergan · 1 shared drug class
  5. Daewoong Pharmaceutical Co. LTD. · 1 shared drug class
  6. Derm Research, PLLC · 1 shared drug class
  7. Azienda Ospedaliera di Padova · 1 shared drug class
  8. Eye & ENT Hospital of Fudan University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for China International Neuroscience Institution:

Cite this brief

Drug Landscape (2026). China International Neuroscience Institution — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/china-international-neuroscience-institution. Accessed 2026-05-17.

Related